Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹243 Cr
down ₹3.7 Cr vs Nov 2019
- Stocks held
- 22
- unchanged
- Top 10 weight
- 62.9%
- of the portfolio in its ten largest
- Cash & debt
- 2.6%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 7
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In December 2019 it disclosed 22 stocks worth ₹243 Cr, down ₹3.7 Cr from Nov 2019. Its largest positions were Dr. Reddy's Laboratories Limited (10.4%), IPCA Laboratories Limited (9.6%), JB Chemicals & Pharmaceuticals Limited (6.9%); the ten largest together made up 62.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.9% of its equity. Cash and debt stood at 2.6%. Compared with Nov 2019 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
37%
Holds more cash than 37% of peers
What these mean: concentration · cash
Holdings in December 2019
Download CSVEvery line the fund disclosed, with the change against Nov 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Dr. Reddy's Laboratories Limited | 10.41% | up 1.98 pts | ₹25.3 Cr | up ₹4.5 Cr | Added |
| IPCA Laboratories Limited | 9.63% | down 1.85 pts | ₹23.4 Cr | down ₹4.9 Cr | Trimmed |
| JB Chemicals & Pharmaceuticals Limited | 6.94% | up 2.40 pts | ₹16.9 Cr | up ₹5.7 Cr | Added |
| Divi's Laboratories Limited | 6.80% | up 0.32 pts | ₹16.6 Cr | up ₹53 L | Added |
| Sun Pharmaceutical Industries Limited | 6.12% | down 6.26 pts | ₹14.9 Cr | down ₹15.7 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 5.85% | up 0.09 pts | ₹14.2 Cr | up ₹1 L | Held |
| Indoco Remedies Limited | 5.37% | up 0.86 pts | ₹13.1 Cr | up ₹1.9 Cr | Added |
| Jubilant Pharmova Limited | 4.15% | up 0.27 pts | ₹10.1 Cr | up ₹50 L | Added |
| Max India Limited | 3.86% | up 0.29 pts | ₹9.4 Cr | up ₹57 L | Added |
| Syngene International Limited | 3.77% | up 0.09 pts | ₹9.2 Cr | up ₹9 L | Added |
| Procter & Gamble Health Limited | 3.55% | up 0.08 pts | ₹8.6 Cr | up ₹6 L | Added |
| Torrent Pharmaceuticals Limited | 3.46% | up 0.96 pts | ₹8.4 Cr | up ₹2.2 Cr | Added |
| Abbott India Limited | 3.39% | up 0.18 pts | ₹8.3 Cr | up ₹31 L | Added |
| Alembic Pharmaceuticals Limited | 3.37% | up 0.16 pts | ₹8.2 Cr | up ₹28 L | Added |
| Abiomed Inc | 3.18% | down 0.52 pts | ₹7.8 Cr | down ₹1.4 Cr | Trimmed |
| Alkem Laboratories Limited | 2.86% | up 0.02 pts | ₹7 Cr | down ₹5 L | Trimmed |
| Unichem Laboratories Limited | 2.86% | down 0.03 pts | ₹7 Cr | down ₹18 L | Trimmed |
| Aarti Drugs Limited | 2.83% | up 0.33 pts | ₹6.9 Cr | up ₹71 L | Added |
| Abbott Laboratories | 2.82% | up 0.07 pts | ₹6.9 Cr | up ₹6 L | Added |
| Ajanta Pharma Limited | 2.65% | down 0.02 pts | ₹6.4 Cr | down ₹15 L | Trimmed |
| Cash, TREPS & receivables | 2.62% | up 0.61 pts | ₹6.4 Cr | up ₹1.4 Cr | Added |
| Dr. Lal Path Labs Limited | 1.93% | down 0.07 pts | ₹4.7 Cr | down ₹23 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.57% | up 0.05 pts | ₹3.8 Cr | up ₹7 L | Added |
What changed, Nov 2019 to Dec 2019
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- JB Chemicals & Pharmaceuticals Limitedup ₹5.7 Cr (+2.40% pts)
- Dr. Reddy's Laboratories Limitedup ₹4.5 Cr (+1.98% pts)
- Torrent Pharmaceuticals Limitedup ₹2.2 Cr (+0.96% pts)
- Indoco Remedies Limitedup ₹1.9 Cr (+0.86% pts)
- Aarti Drugs Limited ₹71 L (+0.33% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2019, the weight rose most in Pharmaceuticals (+1.0 pts), and fell most in Pharmaceuticals & Biotechnology (−1.1 pts).
- Pharmaceuticals10.4% → 11.3%+1.0 pts
- Pharmaceuticals & Biotechnology69.0% → 67.9%−1.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2018 | Jun 2019 | Sep 2019 | Nov 2019 | Dec 2019 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.9% | 70.0% | 69.2% | 69.0% | 67.9% |
| Healthcare Services | 16.6% | 16.2% | 17.7% | 19.1% | 19.1% |
| Pharmaceuticals | 10.7% | 11.7% | 11.5% | 10.4% | 11.3% |
| Insurance | 2.7% | 2.1% | 1.6% | 1.6% | 1.6% |
Allocation in Dec 2019change vs Nov 2019
- Pharmaceuticals & Biotechnology (13)67.9%▼ 1.1 pts
- Healthcare Services (5)19.1%
- Pharmaceuticals (3)11.3%▲ 1.0 pts
- Insurance (1)1.6%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Dec 2019
2.6%
▲ 0.6 pts vs Nov 2019
- Cash alone
- 2.6%
- cash and net receivables
- A year earlier
- 28.6%
- Dec 2018 · now ▼ 25.9 pts
- Last 12 months
- 1.7% – 19.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.